Related Experiment Video
Updated: Mar 25, 2026

04:36
Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
1.7K
Current and Next Generation Portable Screening Devices for Diabetic Retinopathy
J Morgan Micheletti1, Andrew M Hendrick1, Farah N Khan2
1Department of Ophthalmology, Emory University School of Medicine, Atlanta, GA, USA.
Journal of Diabetes Science and Technology
|February 19, 2016
Summary
New technologies show promise for diabetic retinopathy (DR) screening, offering cost-effective solutions. Further research is needed to confirm their effectiveness when used by non-specialists for widespread DR screening.
Area of Science:
- Ophthalmology
- Medical Technology
- Public Health
Background:
- Diabetic retinopathy (DR) is a leading cause of blindness in the US.
- The global diabetes epidemic is increasing DR incidence, necessitating cost-effective screening.
- Current DR screening strategies face global compliance challenges.
Purpose of the Study:
- To review current and emerging technologies for diabetic retinopathy screening.
- To assess the potential of new tools to improve screening efficiency and patient care.
- To identify the most cost-effective methods for DR screening.
Main Methods:
- Review of available and developing technologies for DR screening.
- Analysis of preliminary results from smartphone-based, "all-in-one", and alternative devices.
- Comparison of emerging technologies with current telemedicine and fundus examination.
Main Results:
- Emerging technologies, including smartphone-based and "all-in-one" devices, show encouraging preliminary results.
- The utility of these new technologies requires verification by non-ophthalmic personnel.
- Further research is needed to validate these techniques against established methods.
Conclusions:
- New technologies offer potential advancements for diabetic retinopathy screening.
- Validation studies are crucial to confirm the effectiveness and cost-efficiency of these tools.
- Successful implementation could improve global compliance with DR screening strategies.

